A detailed history of Dixon Hubard Feinour & Brown Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dixon Hubard Feinour & Brown Inc holds 62,172 shares of BMY stock, worth $3.66 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
62,172
Previous 64,897 4.2%
Holding current value
$3.66 Million
Previous $4.74 Million 1.01%
% of portfolio
0.57%
Previous 0.47%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$72.62 - $79.98 $197,889 - $217,945
-2,725 Reduced 4.2%
62,172 $4.79 Million
Q1 2022

May 09, 2022

BUY
$61.48 - $73.72 $232,701 - $279,030
3,785 Added 6.19%
64,897 $4.74 Million
Q4 2021

Jan 10, 2022

BUY
$53.63 - $62.52 $429,576 - $500,785
8,010 Added 15.08%
61,112 $3.81 Million
Q3 2021

Oct 19, 2021

BUY
$59.17 - $69.31 $946 - $1,108
16 Added 0.03%
53,102 $3.14 Million
Q2 2021

Aug 23, 2021

SELL
$61.91 - $67.42 $125,058 - $136,188
-2,020 Reduced 3.67%
53,086 $3.55 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $56,847 - $63,936
-958 Reduced 1.71%
55,106 $3.48 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $12,921 - $14,319
-225 Reduced 0.4%
56,064 $3.38 Million
Q2 2020

Jul 31, 2020

BUY
$54.82 - $64.09 $43,581 - $50,951
795 Added 1.43%
56,289 $3.35 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $136,462 - $198,311
-2,941 Reduced 5.03%
55,494 $3.09 Million
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $5,413 - $7,060
-110 Reduced 0.19%
58,435 $3.75 Million
Q3 2019

Nov 13, 2019

BUY
$42.77 - $50.71 $4,277 - $5,071
100 Added 0.17%
58,545 $2.97 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $69,874 - $77,266
-1,566 Reduced 2.61%
58,445 $2.65 Million
Q1 2019

May 17, 2019

SELL
$45.12 - $53.8 $28,651 - $34,163
-635 Reduced 1.05%
60,011 $2.86 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $72,896 - $94,528
-1,495 Reduced 2.41%
60,646 $3.15 Million
Q3 2018

Nov 06, 2018

SELL
$55.19 - $62.25 $78,645 - $88,706
-1,425 Reduced 2.24%
62,141 $3.86 Million
Q2 2018

Jul 25, 2018

SELL
$50.53 - $62.98 $43,304 - $53,973
-857 Reduced 1.33%
63,566 $3.52 Million
Q1 2018

May 14, 2018

BUY
$59.92 - $68.98 $161,184 - $185,556
2,690 Added 4.36%
64,423 $4.08 Million
Q4 2017

Feb 20, 2018

BUY
$59.94 - $65.35 $42,617 - $46,463
711 Added 1.17%
61,733 $3.78 Million
Q3 2017

Nov 08, 2017

BUY
$55.23 - $63.74 $3.37 Million - $3.89 Million
61,022
61,022 $3.89 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Dixon Hubard Feinour & Brown Inc Portfolio

Follow Dixon Hubard Feinour & Brown Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Hubard Feinour & Brown Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dixon Hubard Feinour & Brown Inc with notifications on news.